A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®

NCT05217810 · clinicaltrials.gov ↗

RECRUITING

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

OTHER: Atectura inhalation capsule (150/80ug)
OTHER: Atectura inhalation capsule (150/160ug)
OTHER: Atectura inhalation capsule (150/320ug)

Sponsor

Novartis Pharmaceuticals